Soleno Therapeutics soleno.life


Public list: Pharma Startups (4734) Portfolio Company Matchmaking M&A (394) Rare Diseases (230)

Soleno Therapeutics (Soleno) is focused on the development and commercialization of therapeutics for the treatment of rare diseases. The company is advancing its lead candidate, DCCR, a once-daily oral tablet for the treatment of PWS, into a Phase III clinical development program at the end of 2017. PWS is a rare and complex genetic neurobehavioral/metabolic disorder affecting appetite, growth, metabolism, cognitive function and behavior. DCCR has received Orphan Drug Designation from the US FDA...Show all

Soleno Therapeutics (Soleno) is focused on the development and commercialization of therapeutics for the treatment of rare diseases. The company is advancing its lead candidate, DCCR, a once-daily oral tablet for the treatment of PWS, into a Phase II...Show all

Company (IPO / Went public)

Phone: 650-213-8444

Fax:

1235 Radio Road
Suite 110
Redwood City, 94065
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Soleno Therapeutics $16.5M Dec 19, 2018
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Soleno Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 4 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 16 competitors